|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3129063 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15719011.7 |
| Date of filing the European patent application | 2015-04-10 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
| (46) | Date of publication of the claims translation | 2021-06-25 |
| (86) | Number | PCT/JP2015/002020 |
| Date | 2015-04-10 |
| (87) | Number | WO 2015/155998 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 2014081454 | 2014-04-10 | JP |
| (72) |
HETTMANN, Thore, DE
ABRAHAM, Reimar, DE
BLUM, Sabine, DE
UENO, Suguru, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426,
JP
Daiichi Sankyo Europe GmbH, Zielstattstr. 48, 81379 München, DE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-HER3 antikūno-vaisto konjugatas |
| ANTI-HER3 ANTIBODY-DRUG CONJUGATE |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 12 | 289.00 EUR |
| 2027-04-10 |